- €277.50m
- €381.56m
- €2.08bn
Medios slips after lower earnings, narrowing guidance
Germany's Medios 9M EBITDA pre falls on price declines
Brief: Medios Sees EUR 3.4 Mln Annual Caelo Synergies From 2028/29
Brief: Luxempart: increased its stake in pharma services company Medios AG to over 20%
Europe Research Roundup: ABN Amro Bank, Kingfisher, Vodafone
Brief: Medios Completes Caelo Acquisition
Brief: Medios Sets Out Ambition 2031 €3.1 Billion Revenue And A Doubling Of EBITDA Adjusted
Germany's Medios H1 profit hit by pricing pressure; to buy 74% of Caelo to expand API
Brief: Medios Reports H1 Group Revenue Up By 8.4% To €1.07 Billion
Brief: Medios H1 Revenue EUR 1,074.9 Million
Brief: Medios To Buy 74% Stake In Caesar & Loretz
Germany's Medios cuts 2026 EBITDA outlook on pharma supply price pressure
Brief: Medios H1 ADJ-EBITDA EUR 44 Million
Brief: Medios To Close Aschaffenburg Facility And Consolidate Manufacturing In Germany
Brief: Medios Extends Executive Board Contract Of Constantijn Van Rietschoten Until April 2030
Germany's Medios Q1 revenue rises, confirms 2026 guidance
Brief: Medios Q1 Revenue EUR 527.6 Million
Germany's Medios 2025 revenue beats estimates on international business expansion
Brief: Medios FY Revenue EUR 2,078.7 Million Vs. IBES Estimate EUR 2,014 Million